Brown Lab News

​Clinical Challenges: Selecting First-Line Therapy in CLL
https://www.medpagetoday.com/clinical-challenges/asco-leukemia/79936

Extended RESONATE Data Illuminates Ibrutinib's Benefits in High-Risk CLL
www.targetedonc.com/publications/targeted-therapy-news/2016/april-2016/extended-resonate-data-illuminates-ibrutinibs-benefits-in-high-risk-cll

New protein-targeting drug shows promise in early trial for patients with high-risk CLL
​https://www.dana-farber.org/newsroom/news-releases/2013/new-protein-targeting-drug-shows-promise-in-early-trial-for-patients-with-high-risk-cll/​